Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)

Conditions

• Hematologic Cancer
• Relapse Leukemia
• Relapsed Adult ALL
• Relapsed Adult AML
• Relapsed CLL
• Relapsed Non Hodgkin Lymphoma
• Relapsed Hodgkin's Lymphoma
• Relapsed Myelodysplastic Syndromes
• Relapsed Multiple Myeloma

Interventions

• BIOLOGICAL: GLIDE

Sponsor

Ciusss de L'Est de l'Île de Montréal